# US 2025/0092381 A1 · Methods and compositions for target detection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0092381 A1
- Document ID: US20250092381A1
- Status: Published application
- Kind: A1
- Application number: 18/643,877
- Filed: 2024-04-23
- Published: 2025-03-20
- Earliest claimed: 2016-02-23
- Assignees: Arc Bio, LLC
- Applicants: Arc Bio, LLC
- Inventors: Stephane B. GOURGUECHON; Meredith L. CARPENTER; Eric HARNESS
- Web page: https://patentgrep.com/patent/US20250092381A1

## CPC

- C12N 15/102: {Mutagenizing nucleic acids}
- C12N 9/16: acting on ester bonds (3.1)
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 15/63: Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 2521/301: Endonuclease
- C12Q 2563/173: staining/intercalating agent, e.g. ethidium bromide
- C12Q 2565/531: characterised by the capture moiety being a protein for target oligonucleotides
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Provided herein are methods and compositions for the detection and identification of targets in a sample, using target-specific guide nucleic acids and nucleic acid-guided nuclease system proteins.

## Claims

### Claim at position 1

1-121. (canceled)

### Claim 122

A method of identifying a target nucleic acid in a sample comprising:
a. providing a plurality of guide nucleic acid (gNA)-nucleic acid-guided nuclease system protein complexes, wherein the complexes are targeted to at least one target nucleic acid, wherein the gNA-nucleic acid-guided nuclease system protein complexes are attached to a substrate, wherein the substrate is silica, plastic, glass, metal, silicon, silica-based materials, functionalized polystyrene, functionalized polyethylene glycol, functionalized organic polymers, nitrocellulose or nylon membranes, paper, or cotton;
b. contacting nucleic acids from a sample with the plurality of gNA-nucleic acid-guided nuclease system protein complexes, wherein the nucleic acids are labeled with an intercalating dye, and wherein the nucleic acids are sheared prior to step (b);
c. washing the substrate to remove the unbound nucleic acids; and
d. identifying the target nucleic acid in the sample;
wherein the identifying is achieved by detecting a signal produced by the intercalating dye on the substrate, wherein the presence of the signal indicates binding of the gNA-nucleic acid-guided nuclease system protein complex to the target nucleic acid.

### Claim 123 (depends on 122)

The method of claim 122, wherein the nucleic acids from the sample are labeled prior to the contacting step.

### Claim 124 (depends on 122)

The method of claim 122, wherein the nucleic acids from the sample are labeled after the contacting step.

### Claim 125 (depends on 122)

The method of claim 122, wherein the nucleic acid-guided nuclease system protein is a CRISPR/Cas system protein.

### Claim 126 (depends on 125)

The method of claim 125, wherein the CRISPR/Cas system protein is selected from the group consisting of Cas9, CasX, CasY, Cpf1, Cas3, Cas8a-c, Cas10, Csel, Csyl, Csn2, Cas4, Csm2, and Cm5.

### Claim 127 (depends on 126)

The method of claim 126, wherein the nucleic acid-guided nuclease system protein is a dead nucleic acid-guided nuclease system protein.

### Claim 128 (depends on 127)

The method of claim 127, wherein the nucleic acid-guided nuclease system protein is dCas9.

### Claim 129 (depends on 126)

The method of claim 126, wherein the nucleic acid-guided nuclease system protein is a nucleic acid-guided nuclease system nickase protein.

### Claim 130 (depends on 122)

The method of claim 122, wherein the sample is selected from the group consisting of a clinical sample, a forensic sample, an environmental sample, a metagenomic sample, and a food sample.

### Claim 131 (depends on 122)

The method of claim 122, wherein the sample is from a human.

### Claim 132 (depends on 122)

The method of claim 122, wherein the complexes are targeted to a plurality of target nucleic acids.

### Claim 133 (depends on 122)

The method of claim 122, wherein the target nucleic acid is indicative of an individual.

### Claim 134 (depends on 122)

The method of claim 122, wherein the target nucleic acid is indicative of a pathogen.

### Claim 135 (depends on 122)

The method of claim 122, wherein the gNA-nucleic acid-guided nuclease system protein complexes comprise at least 1 unique gNA.

### Claim 136 (depends on 122)

The method of claim 122, wherein the nucleic acid is amplified.

### Claim 137 (depends on 122)

The method of claim 122, wherein the nucleic acid is blocked at one or more termini with non-extendible nucleotides.

### Claim 138 (depends on 122)

The method of claim 122, wherein a plurality of targets are simultaneously identified.

### Claim 139 (depends on 138)

The method of claim 138, wherein the sample is subject to multi-detection steps.

### Claim 140 (depends on 122)

The method of claim 122, wherein the method is carried out in less than 24 hours.

### Claim 141 (depends on 122)

The method of claim 122, wherein the nucleic acid comprises or consists of DNA.

### Claim 142 (depends on 122)

The method of claim 122, wherein the gNA-nucleic acid-guided nuclease system protein complexes are attached to a substrate in a referenceable order.

### Claim 143 (depends on 122)

The method of claim 122, wherein the nucleic-acid guided nuclease is attached to the substrate.

### Claim 144 (depends on 143)

The method of claim 143, wherein the nucleic acid-guided nuclease is a Cas9 nuclease.

### Claim 145 (depends on 122)

The method of claim 122, wherein the complexes are targeted to at least 10 targets and wherein identifying comprises identifying the at least 10 targets in the sample.

### Claim 146

A method of identifying a target nucleic acid in a sample comprising:
a. contacting nucleic acid from a sample with a plurality of guide nucleic acid (gNA)-nucleic acid-guided nuclease system protein complexes attached to a substrate, wherein the substrate is silica, plastic, glass, metal, silicon, silica-based materials, functionalized polystyrene, functionalized polyethylene glycol, functionalized organic polymers, nitrocellulose or nylon membranes, paper, or cotton, wherein the complexes are targeted to at least one target nucleic acid, wherein the nucleic acid from the sample comprises a first intercalating dye label and the gNA-nucleic acid-guided nuclease system protein complexes comprise a second label, and wherein the nucleic acid is sheared prior to use in step (a); and
b. identifying the target nucleic acid in the sample, wherein the identifying is achieved by detecting co-localization of the first label and the second label or by detecting a specific signal from the first label and the second label, wherein the co-localization of the first label and the second label or the presence of the specific signal indicates binding of the gNA-nucleic acid-guided nuclease system protein complex to the target nucleic acid.

### Claim 147 (depends on 146)

The method of claim 146, wherein the nucleic acid and the plurality of the gNA-nucleic acid-guided nuclease system protein complexes are both labeled prior to the contacting step.

### Claim 148 (depends on 146)

The method of claim 146, wherein the nucleic acid is labeled after contacting, and the plurality of the gNA-nucleic acid-guided nuclease system protein complexes are labeled before the contacting step.

### Claim 149 (depends on 146)

The method of claim 146, wherein the first and second label comprise a donor/acceptor pair for fluorescent resonance energy transfer.

### Claim 150 (depends on 146)

The method of claim 146, wherein the identifying comprises detecting multiple signals.

### Claim 151 (depends on 150)

The method of claim 150, wherein the nucleic acid, the gNA-nucleic acid-guided nuclease system protein complexes, or both the nucleic acid and the gNA-nucleic acid-guided nuclease system protein complexes comprise multiple labels.

### Claim 152 (depends on 146)

The method of claim 146, wherein the gNA-nucleic acid-guided nuclease system protein complexes are attached to a substrate in a referenceable order.

### Claim 153 (depends on 146)

The method of claim 146, wherein the nucleic-acid guided nuclease is attached to the substrate.

### Claim 154 (depends on 153)

The method of claim 153, wherein the nucleic acid-guided nuclease is a Cas9 nuclease.

### Claim 155 (depends on 146)

The method of claim 146, wherein the complexes are targeted to at least 10 targets and wherein identifying comprises identifying the at least 10 targets in the sample.
